Multiple sclerosis (MS) is a disease of the brain and the mind. Emotional changes, abnormalities of affective expression and cognitive decline have been recognised since the turn of the century but, with a few exceptions"2 have been overlooked, until new imaging techniques made it possible to study brain pathology in vivo. We have learnt much about the psychiatric features and patterns of cognitive impairment and the frequency with which they occur, but the link with brain pathology has proved more elusive. The multifaceted interactions between environmental and organic factors in the causation of psychiatric and cognitive abnormalities and the fluctuations in lesion size and number, often without overt clinical manifestations, need to be better understood before the psychopathology of MS can be fully explained.
Psychiatric abnormalities Transient mood changes, irritability and anxiety are the rule rather than the exception in MS. Two thirds of patients experience these symptoms in the course of a year and in a third they will be severe enough to merit the diagnosis of major depression.3 A life time prevalence for this diagnosis ranges from 40-50%4 while an increased association with bipolar affective disorder has also been found.56 Fatigue, common to both MS and depression, cannot account for this increased morbidity. Transient hypomanic episodes may occur in association with steroid teatment7 and affective symptoms in general are more common during exacerbations8 and in patients with a chronic progressive course,9 but they are not closely related to the degree of physical disability.'0 1' The vulnerability of MS patients to psychiatric illness is comparable to that of patients with temporal lobe epilepsy'2 and much higher than in the general population3 or similarly disabled patients without brain disease." These facts, added to the observation that the family history and incidence of psychiatric illness before the onset of neurological symptoms are similar to those in the general population, ' Euphoria is best defined as a state of elated mood with a happy and cheerful outlook and eutonia, a milder variety of euphoria, as an apparent lack of concern about the severity and implications of the disease. These static mood changes are more akin to a personality change than to an affective disorder. The severity of brain pathology, as shown by MRI, is correlated with the presence of euphoria and eutonia." Pathological laughing and crying, an abnormal display ofemotion without subjective mood changes, is also rare. It has been reported to be associated with the presence of pontine, brain stem4 and periventricular lesions'0l' probably causing a frontal disconnection syndrome.
Short lived psychoses with symptoms indistinguishable from schizophrenia, have been reported in MS.'617 As a rule they occur in the absence of positive family history when MS is well established and at a later age than is common for schizophrenia, thus suggesting a causal role for brain pathology. This has recently been corroborated in an MRI study carried out at the National Hospital for Neurology and Neurosurgery'8 where psychotic MS patients were found to have a greater lesion load around both temporal horns than non-psychotic MS patients matched for disease characteristics.
The possibility that psychiatric abnormalities could be the first manifestation of MS has attracted far more attention than the available evidence justifies.'920 Con 34 Evidence that cognitive impairment may be one of the earliest features of the illness, often predating the development of other neurological signs and symptoms, comes from studies of patients with clinically isolated lesions (optic neuritis, brain stem and spinal cord syndromes). While memory35 and attention36 are already impaired in these patients, often in the absence of neurological disability, little is known about the natural history of these deficits. A recent five year follow up of patients with clinically isolated lesions seen at the National Hospital9 has suggested that cognitive decline is closely linked to disease course. Thus whilst a deterioration in attention and memory functions had occurred in those who had entered a chronic progressive phase, there was little evidence of deterioration in those who had not developed further neurological symptoms. This is in keeping with the finding in patients with well established MS, of greater cognitive impairment when the course is chronic progressive rather than relapsing remitting.3738 However, adherence to disease type over time has been shown to be extremely variable"9 and it remains to be seen whether these changes will be paralleled by changes 
